Medical Technical News and Research

RSS
Omalizumab scratches the itch for urticaria patients

Omalizumab scratches the itch for urticaria patients

Even mild sports-related head impacts can affect cognition

Even mild sports-related head impacts can affect cognition

Forceps delivery ‘does not increase atopy risk’

Forceps delivery ‘does not increase atopy risk’

Under-reported drinking major public health concern

Under-reported drinking major public health concern

No increased risk for inflammatory bowel disease with isotretinoin

No increased risk for inflammatory bowel disease with isotretinoin

Mercury exposure raises diabetes risk later in life

Mercury exposure raises diabetes risk later in life

Bisphosphonate link to nonhealing fractures strengthened

Bisphosphonate link to nonhealing fractures strengthened

Sleep quality linked to cannabis lapses

Sleep quality linked to cannabis lapses

Influenza vaccine linked to narcolepsy in children in England

Influenza vaccine linked to narcolepsy in children in England

Telehealth enthusiasm dampened

Telehealth enthusiasm dampened

GLP-1 pancreatitis concerns justified

GLP-1 pancreatitis concerns justified

Fatigue before cancer treatment impacts fatigue afterwards

Fatigue before cancer treatment impacts fatigue afterwards

Lunchroom makeover improves children’s diet

Lunchroom makeover improves children’s diet

Molecular effects of insufficient sleep uncovered

Molecular effects of insufficient sleep uncovered

Syphilis in pregnancy widespread but preventable

Syphilis in pregnancy widespread but preventable

Biomarker for testicular sperm extraction outcome discovered

Biomarker for testicular sperm extraction outcome discovered

Subclinical inflammation predicts macular disease

Subclinical inflammation predicts macular disease

Reduced income lessens chances of at-home death

Reduced income lessens chances of at-home death

COPD benzodiazepine warning

COPD benzodiazepine warning

Natalizumab may be second-line option for pediatric MS patients

Natalizumab may be second-line option for pediatric MS patients